Understanding Engagement Trends in Chondrosarcoma Clinical Trials

Launched by POWER LIFE SCIENCES INC. · Sep 1, 2023

Keywords

ClinConnect Summary

This clinical trial, titled "Understanding Engagement Trends in Chondrosarcoma Clinical Trials," is focused on learning more about the experiences of patients with chondrosarcoma, a type of bone cancer. Researchers want to find out what factors might make it difficult for patients to participate in or complete clinical trials. By collecting and analyzing data from various groups of people, they hope to identify common challenges and trends that can help improve future studies for chondrosarcoma patients.

To be eligible for this trial, participants need to be at least 18 years old and have a confirmed diagnosis of chondrosarcoma. They should also be able to understand the study's purpose and provide their consent to participate. The trial is not yet recruiting participants, but once it starts, those involved can expect to share their experiences and opinions about the trial process. This information will be valuable in making clinical trials more accessible and effective for future patients with chondrosarcoma.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Aged ≥ 18 years old
• • Able to comprehend the investigational nature of the protocol and provide informed consent
• • Diagnosis of chondrosarcoma
• Exclusion Criteria:
• • No diagnosis of chondrosarcoma confirmed
• • Inability to perform regular electronic reporting
• • Patient does not understand, sign, and return consent form